Financial reports
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
14 Feb 20
10-Q
2019 Q3
Quarterly report
4 Nov 19
10-Q
2019 Q2
Quarterly report
5 Aug 19
10-Q
2019 Q1
Quarterly report
3 May 19
10-K
2018 FY
Annual report
21 Feb 19
10-Q
2018 Q3
Quarterly report
2 Nov 18
10-Q
2018 Q2
Quarterly report
2 Aug 18
Current reports
8-K
Completion of Acquisition or Disposition of Assets
10 Feb 21
8-K
Entry into a Material Definitive Agreement
10 Feb 21
8-K
Other Events
29 Jan 21
8-K
Results of Operations and Financial Condition
25 Jan 21
8-K
Submission of Matters to a Vote of Security Holders
14 Jan 21
8-K
Other Events
4 Jan 21
8-K
Other Events
31 Dec 20
8-K
Entry into a Material Definitive Agreement
19 Nov 20
8-K
Voting and Support Agreement
2 Nov 20
8-K
Endurance International Group Reports 2020 Third Quarter Results
2 Nov 20
Registration and prospectus
15-12B
Securities registration termination
23 Feb 21
25-NSE
Exchange delisting
10 Feb 21
POS AM
Prospectus update (post-effective amendment)
10 Feb 21
POS AM
Prospectus update (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Feb 21
S-3/A
Shelf registration (amended)
19 May 20
S-3
Shelf registration
21 Feb 20
424B3
Prospectus supplement
31 Jan 17
Proxies
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
31 Dec 20
DEFA14A
Additional proxy soliciting materials
29 Dec 20
DEFA14A
Additional proxy soliciting materials
22 Dec 20
DEFM14A
Proxy related to merger
14 Dec 20
PREM14A
Preliminary proxy related to merger
1 Dec 20
DEFA14A
Additional proxy soliciting materials
2 Nov 20
DEFA14A
Additional proxy soliciting materials
2 Nov 20
DEFA14A
Additional proxy soliciting materials
9 Apr 20
DEF 14A
Definitive proxy
9 Apr 20
Other
EFFECT
Notice of effectiveness
12 Feb 21
EFFECT
Notice of effectiveness
12 Feb 21
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9 Nov 20
EFFECT
Notice of effectiveness
21 May 20
CORRESP
Correspondence with SEC
19 May 20
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 May 20
CT ORDER
Confidential treatment order
23 Apr 20
CT ORDER
Confidential treatment order
23 Apr 20
UPLOAD
Letter from SEC
3 Mar 20
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
14 Feb 20
Ownership
4
JOSEPH P DISABATO
18 Feb 21
4
Capital Partners VI GmbH & Co KG GS
18 Feb 21
SC 13G/A
GOLDMAN SACHS & CO. LLC
16 Feb 21
SC 13G/A
Capital Research Global Investors
16 Feb 21
SC 13G/A
Okumus Fund Management Ltd.
16 Feb 21
4
JUSTIN SADRIAN
12 Feb 21
4
Chandler Reedy
12 Feb 21
4
James Neary
12 Feb 21
4
Change in insider ownership
12 Feb 21
SC 13D/A
Warburg Pincus Private Equity X, L.P.
12 Feb 21